TMCnet News
Entwistle & Cappucci LLP Announces It Has Filed a Securities Class Action Against Emergent BioSolutions Inc. (NYSE: EBS)Entwistle & Cappucci LLP ("Entwistle & Cappucci" or "E&C") today announced that the firm has filed a securities class action lawsuit on behalf of investors that purchased Emergent BioSolutions Inc.("Emergent" or the "Company") (NYSE: EBS) common stock from April 24, 2020 through April 16, 2021, inclusive. A copy of the complaint is available at: www.entwistle-law.com. Institutions and individuals that invested in Emergent common stock may contact E&C for additional information concerning the litigation and to discuss potential strategies for the recovery of any losses. The action arises from Emergent's pervasive quality control problems at the Company's Bayview COVID-19 vaccine manufacturing facility in Baltimore, Maryland that culminated in the destruction of up to 100 million COVID-19 Johnson & Johnson and AstraZeneca vaccine doses. The complaint alleges, based on documents recently made public, that numerous statements issued by Emergent concerning its manufacturing processes, capabilities, quality control procedures and status as a purported leader in the biopharmaceutical industry were materially false and misleading.
When these facts became public through a series of partial corrective disclosures, the price of Emergent's common stock declined significantly, eliminating over $1.5 billion in market capitalization. If you invested in Emergent BioSolutions common stock, please feel free to contact attorneys Robert N. Cappucci or Joshua K. Porter at 212-894-7200, or via e-mail at [email protected] or [email protected]. About Entwistle & Cappucci Entwistle & Cappucci is a national law firm providing exceptional legal representation to clients globally in the most complex and challenging legal matters. Our practice encompasses all areas of litigation, including securities, antitrust, corporate transactions, general corporate and commercial, creditor's rights and bankruptcy, corporate governance and fiduciary duty, government affairs, insurance, investigations and white-collar defense. Our clients include public and private corporations, major hedge funds, public pension funds, governmental entities, leading institutional investors, domestic and foreign financial services companies, emerging business enterprises and individual entrepreneurs.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210603006004/en/ |